Skip to main content

Table 1 Patients characteristics and doses

From: Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience

Indications

n

Age (Mean ± SD)

Weight (kg) (Mean ± SD)

Gender (%)

Dose (mcg/kg) (Mean ± SD)

All occasions

76

37.93 ± 18.25

61.21 ± 12.28

Male (61.8) Female (38.2)

83.38 ± 24.80

Trauma

22

30.00 ± 15.60

61.57 ± 12.85

Male (81.8) Female (18.2)

92.39 ± 31.68

Peripartum

4

35.75 ± 5.62

59.13 ± 15.70

Male (0) Female (100)

92.08 ± 5.30

Surgery bleedings

9

43.00 ± 15.58

51.64 ± 11.86

Male (71.4) Female (28.6)

77.27 ± 24.21

Medical

41

41.07 ± 19.91

63.42 ± 11.28

Male (56.1) Female (43.9)

79.04 ± 20.66

  1. SD Standard deviation